Expertise in
12
conditions

Annibale Versari

Reggio Nell'emilia, IT 
Expertise in
12
conditions
Reggio Nell'emilia, IT 
OverviewLocationsClinical Research

Overview

Annibale Versari practices in Reggio Nell'emilia, Italy. Mr. Versari is highly rated in 12 conditions, according to our data. His top areas of expertise are Retroperitoneal Fibrosis, Follicular Lymphoma, Vasculitis, Deep Brain Stimulation, and Parathyroidectomy.

His clinical research consists of co-authoring 161 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Reggio Nell'emilia, Italy
Other Locations
Brescia, Italy
Piacenza, Italy
Palermo, 90127, Italy
Cagliari, Italy
Veneto, Italy
Bologna, Italy
Cesena, 47521, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2024
Intervention Type: Drug
Study Drugs: Lutathera, Octreotide
Study Phase: Phase 3
Accuracy and Clinical Impact of 68-Ga-labeled Octreotide Analogues PET in Diagnosis and Staging of Duodenal-pancreatic Neuroendocrine Tumours; Proposal of a Multicenter, Prospective Clinical Trial
Accuracy and Clinical Impact of 68-Ga-labeled Octreotide Analogues PET in Diagnosis and Staging of Duodenal-pancreatic Neuroendocrine Tumours; Proposal of a Multicenter, Prospective Clinical Trial
Enrollment Status: Completed
Publish Date: March 09, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

161 Total Publications

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.
Journal: American journal of hematology
Published: December 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Versari's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile